ArticleNature communications2026
High performance organic solar cell enabled by manipulating the exciton dissociation and charge transfer via dielectric engineering.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
As core processes determining the power conversion efficiency (PCE) of organic solar cells (OSCs), exciton dissociation and charge transfer are fundamentally restricted by the low intrinsic dielectric constant of organic semiconductors. Herein, two dielectric regulators (Drs) named Dr-1 and Dr-2 are judiciously designed with different molecular dipole moments to conduct research on dielectric engineering. The incorporation of S···F noncovalent conformational locks (NoCLs) endows Dr-2 with an extended π-conjugated backbone, improved molecular polarizability, reinforced charge delocalization and a larger dipole moment than Dr-1. Thus, Dr-2-modified OSCs based on the D18:L8-BO system achieve a PCE of 20.85%, surpassing the 20.13% of Dr-1-treated counterparts. Enhanced efficiencies across diverse donor-acceptor systems confirm the universal applicability of this strategy. Furthermore, 300 nm-thick OSCs incorporated with Dr-2 deliver a record-high PCE of 19.56%. This work provides a strategy for designing high-performance dielectric regulators via tuning molecular dipole moment and planarity simultaneously, thereby achieving high-efficiency OSCs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.